Antimycin A, UHDBT and myxothiazol are representatives of different groups of inhibitors of the mitochondria1 bcl complex where they selectively act on the specific sites for quinone reduction and oxidation. We report here their effects on the purified cytochrome bd terminal oxidase complex from Auinelandii which functions as a quinol oxidase. The quinol binding site is, in the E. coli enzyme, located in subunit I which also contains the hewcoordinate haem b558
111. The oxygen reduction site, comprising haems b595 and d, is located on subunit 11. Electron transport is thought to follow the sequence b558 -
The cytochrome bd complex was purified from the overproducing A.vinelundii strain MK8 131 by ammonium sulphate precipitation of a lauryl-maltoside solubilised membrane preparation. Respiratory activity was assayed at pH 7.9 in anoxygen-electrode with up to 150 pM ubiquinol-1 plus 1mM DTT or 0.5 mM TMPD plus 2 mM sodium ascorbate as substrates. The purified cytochrome bd complex is inhibited by antimycin A and UHDBT with ubiquinol-1 plus DTT as respiratory susbstrate while the TMPD oxidase activity is unaffected. Myxothiazol has no inhibitory effect with either substrate. Inhibition by antimycinA andUHDBT was found to be non-competitive with Ki=Ki'z (1133) pM and (Z(H5) pM, respectively. TMPD oxidation by the E m f i enzyme has been shown to be uneffected by trypsin digestion of subunit I, a procedure which completely abolishes ubiquinol oxidation Ill. The lack of inhibition of TMPD oxidation by antimycin A and UHDBT in the present experiments confirms the presence of a different electron entry point for the two substrates and suggests that the effect of these inhibitors is on the electron transfer pathway prior to haem b595 and d. In order to further localise the site of inhibition by antimycin A, we have followed the spectral changes of the oxidase at 560 nm during reduction with ubiquinol-1 (Fig. 1) . At this wavelength the reduced forms of haem b558 and haem b595 both absorb 141. After addition of substrate to uninhibited enzyme, a period of steady state respiration is observed followed, on anaerobiosis, by a sharp rise in absorbance, to about W90% of the fully reduced spectrum. In antimycin A inhibited samples, the steady state level of haem b reduction is increased, as is, Fig. 1 correspondingly, the time taken to anaerobiosis. Again, a fast phase of reduction is observed, the amount of which decreases with rising inhibitor concentrations, to a minimum of about 50% of the total change. The remaining haem b is reduced slowly at a rate of about 0.002 s-l, a value much slower than the apparent rate of turnover in the same inhibited sample (about 2 s-l, estimated from the time taken to anaerobiosis). This could be explained assuming that the binding of antimycin A renders an oxidase molecule completely inactive, so that the sample contains a mixture of fully active (showing turnover and fast reduction) and fully inactive molecules (slow reduction at0.002 s-l), the ratio of which depends on the inhibitor concentration. A similar mechanism has been reported for the non-competitive inhibition of cytochrome c oxidase by psychosine 151. The reduction of haems b595 and d (monitored at 595-604 nm and 628-604 nm, respectively) always occured at a fast rate, even at antimycin concentrations sufficient to inhibit respiration by about 90%, suggesting that the slow phase of haem b reduction at 560 nm can be attributed to haem b.558. This is confirmed by the kinetic spectrum of the slow component ( Fig. 2) which is typical of a low-spin b -type haem, without contributions from haem b595 or d. Thus ubiquinol can donate electrons directly to haem b595, bypassing the antimycin block. We therefore conclude that the electron transfer pathway from ubiquinol to the oxygen reduction site is branched, with two one electron donations to haem b5.g and haem b595, respectively.
